Eagles Face Criticism Over Handling Of Jalen Hurts’ Blood Clotting Condition
The Philadelphia Eagles are facing criticism over their handling of a serious blood clotting condition affecting their star quarterback, Jalen Hurts, who will consequently miss the remainder of the season.
Sioux Falls, SD, October 20, 2026 —
The Philadelphia Eagles are facing criticism over their handling of a serious blood clotting condition affecting quarterback Jalen Hurts. Hurts will miss the remainder of the season, according to the information provided.
The details available do not identify who has criticized the team or explain what aspects of its handling of the condition prompted the criticism. They also do not specify when Hurts’ condition was identified, what care he received, or how the decision about his availability was made.
The condition is described as serious, but no further medical information is provided. The summary does not state whether the Eagles have issued a response, whether Hurts or his representatives have commented, or whether any other parties have addressed the criticism. It also does not provide a date for the announcement or identify the season involved.
As a result, the reported situation is limited to two points: Hurts is expected to miss the rest of the season because of the blood clotting condition, and the Eagles are facing criticism over their handling of it. Without additional information, the nature and basis of that criticism cannot be established.
The Eagles’ handling of the matter remains the focus of the criticism described in the summary. No specific allegation, response, or further development was provided, leaving those aspects of the story unclear.
Story summarized from the original created by Dominick Mastrangelo on thehill.com, see more information here.
Media gallery
